The global endoscopy devices market size valued at USD 35.14 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 7.4% from 2019 to 2025. Increase in preference for minimally invasive endoscopic procedures and global geriatric population are key factors boosting demand for endoscopes. The market is also being driven by an increase in prevalence of gastrointestinal, urological, gynecological, and respiratory disorders, which necessitates endoscopic procedures for diagnosis & treatment. Rise in adoption of endoscopes and visualization systems in healthcare settings, coupled with technological advancements, is aiding growth.
Significant increase in prevalence of age-related diseases and rise in demand for endoscopy devices in diagnostic & therapeutic procedures are factors driving the market. The use of such devices in diagnosis and treatment of multiple conditions is essential as it enables minimal intervention, resulting in a shorter recovery time. Geriatric population is known to be prone to medical conditions that need endoscopic procedures, such as intestinal perforation, gall stones, pelvic abscess, endometriosis, and liver abscess. According to a study by Population Reference Bureau, the number of people aged 65 years or above in the U.S. was estimated at 52.0 million in 2018 and is expected to cross 95 million by 2060. This is projected to boost the demand for endoscopic procedures over the forecast period.
Increasing adoption of minimally invasive surgeries has propelled usage of various endoscopes in surgical procedures, such as arthroscopy, laparoscopy, bronchoscopy, and cystoscopy. Compared to open surgeries, these procedures result in quicker recovery and lesser trauma to patients. Thus, minimally invasive surgical procedures are being preferred over open/invasive surgeries and are thereby likely to increase demand for minimally invasive endoscopic devices over the coming years. The shift toward minimally invasive surgeries can also attributed to higher patient satisfaction, economic viability, relatively shorter hospital stay, and reduced postsurgical complications. Thus, demand for minimally invasive endoscopic surgeries is expected to increase over the coming years.
Increase in prevalence of cancer & obesity and the introduction of endoscopic bariatric surgeries-owing to growing trend of preventive healthcare-are key factors contributing to growth of this market. According to estimates by International Agency for Research on Cancer, in 2018, global cancer burden was estimated to reach 18.1 million new cases and 9.6 million cancer-related deaths were anticipated. Cancer burden is anticipated to increase to 22 million by 2034.
Lung, colorectal, and female breast cancers are among the top five cancers in terms of mortality. Endoscopic procedures, such as laryngoscopy, colonoscopy, and upper endoscopy, are used to diagnose cancer, which is also projected to increase demand for endoscopic devices. Various initiatives undertaken for creating awareness about early cancer diagnosis are also boosting the demand for cancer screening procedures, thereby positively impacting the market.
In 2018, endoscopy visualization systems accounted for the highest revenue share. This can be attributed to increasing preference for HD visualization systems by medical professionals, as they can help in diagnosis & treatment of complex diseases such as cancer, GI disorders, lung disorders, & urinary disorders and during minimally invasive surgical procedures. Manufacturers offering HD visualization systems capable of switching images from 2D to 3D for medical professionals is also creating a positive impact on the market.
The endoscopes segment is expected to grow at a lucrative CAGR of 8.8% over the forecast period. Flexible endoscopes accounted for the highest revenue share in 2018, owing to increasing preference due to better ergonomics, safety, and efficacy over rigid endoscopes. Increased focus of manufacturers on offering training for optimal use of advanced flexible endoscopes is further expected to positively impact the market.
Endoscopy visualization components registered a significant growth in global endoscopy devices market, wherein HD monitors accounted for the highest revenue in 2018. Technological modifications, such as camera heads with optical zoom that allows magnification adjustment without hampering image resolution, and rise in public & private sector investments are among the major factors aiding growth of the global market.
In 2018, GI endoscopy was the largest application segment and accounted for a revenue share of 54.6%. The increasing burden of GI diseases, coupled with growing geriatric population, is driving the demand for GI endoscopy. GI tumors are the second largest cause of cancer-related deaths worldwide. Endoscopy has proved to be the gold standard for diagnosis of GI cancers. Thus, increase in endoscopic procedures for early diagnosis of GI cancers is expected to offer considerable revenue opportunities in the market.
Urology endoscopy, also known as cystoscopy, is expected to grow at the fastest rate of 9.0% over the forecast period. Increase in factors such as the overall geriatric population, prevalence of urinary disorders, and the number of ureteroscopic interventions performed have further boosted demand for these endoscopy devices. According to a 2019 report published by the American Cancer Society, an estimated 80,470 people in U.S. are diagnosed with bladder cancer annually. An estimated 17,670 deaths due to bladder cancer are expected to occur in 2019. Thus, demand for urology endoscopes is expected to increase over the coming years.
In addition, introduction of advanced endoscopic techniques in urology, such as robot-assisted endoscopes or disposable endoscopes, is among the top contributing factors driving the market. Moreover, ongoing product approvals by the FDA for urological endoscopy, such as the single-use cystoscope named Uro-V by UroViu Corporation, are expected to drive the market.
In 2018, hospitals emerged as the largest end-user segment. As hospitals are the primary health system in a majority of countries, the number of endoscopic surgeries undertaken at hospitals is comparatively higher than the other health systems, such as Ambulatory Surgical Centers (ASCs) or specialty clinics. Therefore, the demand for endoscopy devices in hospitals is comparatively higher than that in other end-use segments. Hospitals is expected to maintain its dominance due to the abovementioned factor.
The ASCs segment is expected to grow at a significant growth pace over the forecast period. Increasing preference for outpatient surgeries, increase in minimally invasive surgeries, and cost-effectiveness of ASC-based endoscopic procedures are key factors enabling a lucrative growth of this segment. Conversely, lower postsurgical complications in minimally invasive endoscopic surgery are expected to increase the demand in ASCs. Other end users include diagnostic centers, research centers, and specialty clinics. Increase in number of endoscopic procedures for early diagnosis of cancer and technological advancements in endoscopes, visualization systems, & components are collectively aiding the demand for endoscopy devices. These advancements include portability, HD imaging, and microendoscopy, which enable accurate diagnoses and are, therefore, positively impacting demand for endoscopic procedures at diagnostic centers.
In 2018, North America accounted for a leading revenue share, owing to high prevalence of diseases such as bladder & colon cancers, increase in preference for minimally invasive surgeries, and rise in elderly population. In addition, increasing adoption of robot-assisted endoscopes used for diagnostic and surgical procedures is further contributing to market growth.
The U.S. accounts for largest revenue share within North America. Increasing demand for laparoscopies and colonoscopies in the U.S., owing to increasing prevalence of colorectal cancer, can be attributed to the country’s leading revenue share. According to a report by American Cancer Society, colorectal cancer is the third most frequently diagnosed cancer, with 101,420 new cases expected to be recorded in 2019. Moreover, increasing awareness about advantages of endoscopy and strong presence of domestic manufacturers also contributes to the region’s leading revenue share.
Asia Pacific is anticipated to be the most lucrative region, accounting for the highest CAGR of 8.6% during the forecast period. Growing economies of India and China are expected to be significant contributors in this region. This can be attributed to substantial economic growth, increasing prevalence of cancer, improving healthcare infrastructure, and increasing demand for advanced diagnostic therapies.
Olympus accounts for approximately 70% of the revenue share in GI endoscopy. Mergers & acquisitions, high investments on R&D, and new product developments or modifications are among the key strategies adopted by players to gain a competitive edge. Some of the prominent players in the endoscopy devices market include:
Fujifilm Holdings Corporation
Ethicon Endo-Surgery, LLC
Richard Wolf GmbH
Boston Scientific Corporation
Market size value in 2020
USD 40.84 billion
Revenue forecast in 2025
USD 58.11 billion
CAGR of 7.4% from 2019 to 2025
Base year for estimation
2014 - 2017
2019 - 2025
Revenue in USD million and CAGR from 2019 to 2025
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Product, application, end use, region
North America; Europe; Asia Pacific; Latin America; MEA
U.S.; Canada; U.K.; Germany; Spain; Russia; France; Italy; Denmark; Switzerland; China; Japan; India; Australia; Thailand; New Zealand; Indonesia; Malaysia; Vietnam; Philippines; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Israel; Kuwait; Qatar
Key companies profiled
Olympus Corporation; Fujifilm Holdings Corporation; Ethicon Endo-Surgery, LLC; Stryker Corporation; Richard Wolf GmbH; Boston Scientific Corporation; Karl Storz
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, & country levels and provides an analysis on latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global endoscopy devices market report on the basis of product, application, end use, and region:
Product Outlook (Revenue, USD Million, 2014 - 2025)
Other Rigid Endoscopes
Upper Gastrointestinal Endoscopes
Other Flexible Endoscopes
Robot Assisted Endoscopes
Endoscopy Visualization Systems
Standard Definition (SD) Visualization Systems
High Definition (HD) Visualization Systems
Endoscopy Visualization Components
Suction & Irrigation Systems
Application Outlook (Revenue, USD Million, 2014 - 2025)
Gastrointestinal (GI) Endoscopy
Urology Endoscopy (cystoscopy)
End-use Outlook (Revenue, USD Million, 2014 - 2025)
Ambulatory Surgery Centers
Other End Uses
Regional Outlook (Revenue, USD Million, 2014 - 2025)
Middle East & Africa
b. The global endoscopy devices market size was estimated at USD 37.91 billion in 2019 and is expected to reach USD 40.84 billion in 2020.
b. The global endoscopy devices market is expected to grow at a compound annual growth rate of 7.4% from 2019 to 2025 to reach USD 58.11 billion by 2025.
b. Endoscopy visualization systems dominated the endoscopy devices market with a share of 42.7% in 2019. This is attributable to increasing preference for HD visualization systems by medical professionals in diagnosis & treatment of complex diseases.
b. Some key players operating in the endoscopy devices market include Olympus Corporation; Fujifilm Holdings Corporation; Ethicon Endo-Surgery, LLC; Stryker Corporation; Richard Wolf GmbH; Boston Scientific Corporation; and Karl Storz.
b. Key factors that are driving the market growth include significant increase in prevalence of age-related diseases, rise in demand for endoscopy devices in diagnostic & therapeutic procedures, and increasing adoption of minimally invasive surgeries.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPA norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.